{"id":"NCT02792699","sponsor":"Amgen","briefTitle":"Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab","officialTitle":"A Randomized, Double-blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-17","primaryCompletion":"2018-10-08","completion":"2018-10-08","firstPosted":"2016-06-07","resultsPosted":"2019-10-23","lastUpdate":"2020-10-06"},"enrollment":311,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Rheumatoid"],"interventions":[{"type":"DRUG","name":"ABP 798","otherNames":[]},{"type":"DRUG","name":"Rituximab (US)","otherNames":["Rituxan®"]},{"type":"DRUG","name":"Rituximab (EU)","otherNames":["MabThera®"]}],"arms":[{"label":"ABP 798 / ABP 798","type":"EXPERIMENTAL"},{"label":"Rituximab (US) / ABP 798","type":"ACTIVE_COMPARATOR"},{"label":"Rituximab (EU) / Rituximab (EU)","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is designed to determine what effects the human body has on the investigational medicine, ABP 798, and what effects the body has on the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe RA.\n\nThis study will also assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.","primaryOutcome":{"measure":"Area Under the Serum Concentration-time Curve From Time 0 to Infinity (AUCinf) After the Second Infusion of the First Dose","timeFrame":"Day 15, pre-dose, end of infusion, and 3, 6, 24, and 48 hours, and 2, 6, and 10 weeks postdose.","effectByArm":[{"arm":"ABP 798","deltaMin":149398,"sd":36.2},{"arm":"Rituximab (EU)","deltaMin":172463,"sd":32.9},{"arm":"Rituximab (US)","deltaMin":158529,"sd":34.9}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG002","p":null},{"comp":"OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":55,"countries":["United States","Bulgaria","Estonia","Germany","Hungary","Poland"]},"refs":{"pmids":["32627420"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":104},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Rheumatoid arthritis","Nausea","Bronchitis"]}}